AI generated summary of Pubmed citation/abstract with PMID 38093375

https://pubmed.ncbi.nlm.nih.gov/38093375

Chen et al. discover that overexpression of the lncRNA CHKB-AS1 enhances tumor growth and resistance to the renal carcinoma drug NVP-BEZ235 by interacting with MAP4 and regulating the PI3k/Akt/mTOR pathway, contributing to a diminished antitumor effect.